← Leaderboards
Michael A. Ortega
Queen'S Medical Center
$1,186,635
Attributed
$1,186,635
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $667.5K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,186,635 · 2
By mechanism
R21$667,500 · 1
P20$519,135 · 1
Top collaborators
No co-investigators on record.
Most similar at Queen'S Medical Center
Same institution · by research overlap
- Reinhold Penner$9,890,860
Others in their field
Other Rising Stars on “Signal Transduction”
- Suma Babu · Massachusetts General Hospital$20,303,231
- Sabrina Paganoni · Massachusetts General Hospital$20,303,231
- Thomas K Karikari · Wake Forest University Health Sciences$12,972,426
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
- Ian Gurrell · Astrazeneca Pharmaceuticals, Lp$5,256,914
Research focus
Signal TransductionFibroblastsKidney CellRenal FunctionTubular FormationFibroblast Growth Factor ReceptorsApoptosis PromoterKidneyNf-Kappa BNfkb Signaling PathwayInflammationTnf GeneCellsI-Kappa B ProteinsChronicChronic Kidney FailureDisease ProgressionFunctional DisorderFibrosisKidney DiseasesCenters Of Research ExcellenceImpairmentHyperglycemiaGlucose
Grant awards (3)
Non-canonical NF-kB signaling in diabetic kidney disease$245,260
P20 · FY2025 · GM · contact PI
Non-canonical NF-kB signaling in diabetic kidney disease$273,875
P20 · FY2024 · GM · contact PI
TWEAK-Fn14 regulation of non-canonical NF-kB signaling in chronic renal inflammation$667,500
R21 · FY2023 · DK · contact PI